Bladder Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Bladder Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Measurement of minimal residual disease in early stage bladder cancer helps personalize treatment and improve treatment.
ASCO Update - Bavencio immunotherapy superior to improves bladder cancer treatment outcomes.
Trodelvy represents a new treatment option for advanced bladder cancers.